The World Veterinary Association (WVA) and the World Small Animal Veterinary Association (WSAVA) are taking steps to improve the global availability of basic veterinary pharmaceuticals. The first step has been developing lists outlining what these medicines are for various animal species.
The AVMA, Mars Veterinary Health, and other industry leaders have created a comprehensive guide that outlines matching expectations for both veterinary teams and clients, and encourages a supportive, safe, and inclusive environment.
Nearly 120 veterinarians and veterinary students attended the 2023 AVMA annual legislative fly-in, held April 17-19 in Washington, D.C. They urged Congress to support two AVMA-backed bills aimed at ensuring dogs are healthy when imported into the United States and to combat trafficking of the animal sedative xylazine without hindering veterinary access to the drug.
This July in Denver, the AVMA House of Delegates (HOD) will elect the 2023-24 AVMA president-elect from among three candidates: Dr. Sandra Faeh Butler, 2020-22 AVMA vice president; Dr. Arnold L. Goldman, 2017-23 AVMA treasurer; and Dr. Robert Murtaugh, a former chair of the AVMA American Board of Veterinary Specialties.
Two federal agencies are considering transferring oversight of some 600 products from the Environmental Protection Agency (EPA) to the Food and Drug Administration (FDA) Center for Veterinary Medicine (CVM), under a joint proposal being considered by the agencies.
The 9-year-old veterinary specialty in shelter medicine received full recognition from the AVMA American Board of Veterinary Specialties (ABVS) in March, while a new specialty in fish medicine received provisional recognition.